You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. Development of a Coastal Long-Term Automated Self-Calibrating Profiler

    SBC: Green Eyes, LLC            Topic: 814

    Green Eyes, LLC will demonstrate the feasibility of a Coastal Long-term Automated Self-calibration Profiler (CLASP) system capable of operating autonomously for one year without servicing. CLASP will be configured to incorporate wireless two-way communications for automated data dissemination and remote control. Two major innovations are required to develop such a system. 1. Automated bio-fouli ...

    SBIR Phase I 2007 Department of Commerce
  2. Novel Antagonists for Ameliorating Pulmonary Fibrosis

    SBC: AUXAGEN, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Pulmonary fibrosis, a group of incurable lung diseases with high mortality rates, is characterized by inflammatory cell infiltration, fibroblast proliferation, and excessive deposition of extracellular matrix proteins in lung parenchyma. Globally, five million people are affected by pulmonary fibrosis. In the U.S. alone, 200,000 suffer from this disease. Of the ...

    STTR Phase I 2007 Department of Health and Human Services
  3. TOPIC 58-FAMILIES AS RES. and TREATMENT PARTNERS: DEV. EVID. BASED DECISION AIDS FO

    SBC: DANYA INTERNATIONAL, INC.            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  4. INTERNATIONAL COLLABORATION OPPORTUNITIES and RESEARCH PARTNERSHIPS (ICORP)

    SBC: DANYA INTERNATIONAL, INC.            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  5. INTERNATIONAL SUBSTANCE ABUSE DATA RESOURCE CENTER (ISA-DRC)

    SBC: DANYA INTERNATIONAL, INC.            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  6. Epitope-driven deimmunization of Factor VIII

    SBC: EPIVAX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Hemophilia A patients are prone to develop inhibitory immune responses to the very therapy they require: Factor VIII protein replacement. Up to 30% of all hemophiliacs and greater than 50% of severe hemophiliacs produce antibodies (inhibitors) in response to treatment. Immunogenicity to Factor VIII (FVIII) is its most significant complication: immunogenicity no ...

    SBIR Phase I 2007 Department of Health and Human Services
  7. Therapeutic Treatment for Pseudofolliculitis Barbae

    SBC: ISW GROUP, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this Phase II SBIR grant proposal is to demonstrate tolerability and efficacy of an ISW Group, Inc. topical dermatologic formulation developed for the treatment of the human skin disorder Pseudofolliculitis barbae (PFB). PFB is characterized by skin lesions (e.g. "razor bumps"), skin discoloration, and/or irritation. Pseudofolliculitis can affe ...

    SBIR Phase II 2007 Department of Health and Human Services
  8. NIDA INTERNATIONAL VIRTUAL COLLABORATORY

    SBC: JGPERPICH, LLC            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  9. SBIR TOPIC 229 PHARMACODYNAMIC ASSAY FOR CANCER THERAPEUTICS

    SBC: MESO SCALE DIAGNOSTICS, LLC            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
  10. ANTIBODY ARRAY FOR EARLY DETECTION OF LUNG CANCER

    SBC: MESO SCALE DIAGNOSTICS, LLC            Topic: N/A

    N/A

    SBIR Phase I 2007 Department of Health and Human Services
US Flag An Official Website of the United States Government